Larry Dillaha, Chief Executive Officer of CavtheRx, was appointed interim President and Chief Executive Officer of the Company.
Prior to becoming CEO of CavtheRx, Dr. Dillaha was Chief Operating Officer and Chief Medical Officer of New Haven Pharmaceuticals, a specialty pharmaceutical company.
Dr. Dillaha also served as Chief Medical Officer of Insys Therapeutics, Sciele Pharma and as Medical Director of Sanofi-Sythelabo.
He received an M.D. degree from the University of Tennessee, Memphis. ■
LATEST MOVES FROM Texas
- Omega Protein Corporation appoints Celeste Clark to board
- Energy XXI appoints Douglas E. Brooks as CEO
- Kimberly-Clark names Larry P. Allgaier president for North America
- InTech Aerospace promotes Scott Mowery to COO
- Francesca's appoints Philip Bleser to board
More inside POST